Skip to content
healthcare.dev

Terbinafine

NDC 69097-859, Terbinafine, tablet, from Cipla USA Inc..

Product NDC
69097-859
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077533
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-859 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERBINAFINE HYDROCHLORIDE250 mg/1

Pharmacologic classes

Allylamine Antifungal [EPC]; Allylamine [CS]

Package NDCNDC-11Package
69097-859-026909708590230 TABLET in 1 BOTTLE (69097-859-02)
69097-859-0769097085907100 TABLET in 1 BOTTLE (69097-859-07)
69097-859-1269097085912500 TABLET in 1 BOTTLE (69097-859-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/18b16aad-1877-4b07-b532-f0ef4843af91
  • NADAC price for package 69097085902

    GET /v1/drugs/nadac/69097085902
  • NADAC price for package 69097085907

    GET /v1/drugs/nadac/69097085907

Use it

Look up 69097-859 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-859 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-859. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.